We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Coronary Flow Rate Measurement in T-Grafts

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01170988
First Posted: July 28, 2010
Last Update Posted: August 6, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Bethanien Krankenhaus gGmbH
Information provided by (Responsible Party):
Arndt-H. Kiessling, Johann Wolfgang Goethe University Hospitals
July 27, 2010
July 28, 2010
August 6, 2014
August 2010
August 2014   (Final data collection date for primary outcome measure)
Coronary flow reserve [ Time Frame: within 4-6 weeks ]
Same as current
Complete list of historical versions of study NCT01170988 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Coronary Flow Rate Measurement in T-Grafts
Comparison of Coronary Flow Reserve in Two Different Bypass Techniques (T-graft Technique Versus Isolated Graft Technique) Using Magnetic Resonance Technology (MRT)
Is the surgical treatment of patients with coronary heart disease using the T-graft technique an adequate solution that provides a sufficient myocardial flow reserve? A magnetic resonance examination (MRI) is required.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Coronary Heart Disease
Procedure: T-Graft
T-Graft
surgical procedure
T-graft bypass or conventional bypass
Intervention: Procedure: T-Graft
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
August 2014
August 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • coronary heart disease
  • Age > 18 ys
  • Ejection fraction > 45%

Exclusion Criteria:

  • myocardial infarction
  • Re-Intervention
Sexes Eligible for Study: Male
18 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT01170988
FLUSS001AHK
No
Not Provided
Not Provided
Arndt-H. Kiessling, Johann Wolfgang Goethe University Hospitals
Johann Wolfgang Goethe University Hospital
Bethanien Krankenhaus gGmbH
Not Provided
Johann Wolfgang Goethe University Hospital
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP